Erythroplasia of Queyrat treated with imiquimod 5% cream
Authors:
- Giuseppe MicaliGMGiuseppe Micali
- Maria Rita NascaMNMaria Rita Nasca
- Rocco De PasqualeRPRocco De Pasquale
- 1 November 2006
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (5) , 901-903
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001
- Imiquimod: a novel treatment for lentigo malignaBritish Journal of Dermatology, 2000
- Erythroplasia of Queyrat: Coinfection with Cutaneous Carcinogenic Human Papillomavirus Type 8 and Genital Papillomaviruses in a Carcinoma In SituJournal of Investigative Dermatology, 2000
- Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% creamActa Dermato-Venereologica, 2000
- Topical ImiquimodDrugs, 1999
- Treatment of Molluscum Contagiosum in Males with an Analog of Imiquimod 1% in Cream: A Placebo‐Controlled, Double‐Blind StudyThe Journal of Dermatology, 1998
- ReplyJournal of the American Academy of Dermatology, 1998
- Cytokine induction by the immunomodulators imiquimod and S-27609Journal of Leukocyte Biology, 1995